The glucagon-like peptide-1 receptor (GLP-1R) is a class B1 G protein-coupled receptor (GPCR) that is well established as a treatment target for type 2 diabetes (T2D), obesity, and related metabolic diseases [1]. This evidence concerns the gene GLP1R and metabolic disease.